Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Martina Cornel

Professor of Community Genetics and Public Health Genomics

Amsterdam UMC Locatie VUmc

Netherlands

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Tissue Engineering

40%

Health Economics

40%

Medical Science

60%

Assisted Reproductive Technology

50%

Gene Therapy

40%

Genome Editing

40%

Genetic Counseling

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles22

Overcoming treatment implementation barriers for individuals with rare diseases using single-case experimental designs

Article Link

Year:

2025

DNA-poli: Design and development of a digital platform for family communication support and predictive genetic counseling on inherited diseases

Article Link

Year:

2025

Priority-setting criteria for clinical practice guideline development on rare genetic neurodevelopmental disorders: a Delphi study within the European Reference Network ITHACA

Article Link

Year:

2025

A decade of public engagement regarding human germline gene editing: a systematic scoping review

Article Link

Year:

2025

Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data

Article Link

Year:

2025

Information Provision Regarding Health-Related Direct-to-Consumer Genetic Testing for Dutch Consumers: An in-Depth Content Analysis of Sellers’ Websites

Article Link

Year:

2024

The impact of counselors’ values and religious beliefs on their role identity and perspectives on heritable genome editing: a qualitative interview study

Article Link

Year:

2024

Policy Guidance for Direct-to-Consumer Genetic Testing Services: Framework Development Study

Article Link

Year:

2024

Genetic Screening—Emerging Issues

Article Link

Year:

2024

Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233))

Article Link

Year:

2024

Do we care? Reporting of genetic diagnoses in multidisciplinary intellectual disability care: a retrospective chart review

Article Link

Year:

2024

Changes in opinions about human germline gene editing as a result of the Dutch DNA-dialogue project

Article Link

Year:

2023

Correction: Changes in opinions about human germline gene editing as a result of the Dutch DNA-dialogue project

Article Link

Year:

2023

Predictive Value of SLCO1B1 c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-Users

Article Link

Year:

2023

Dealing with ambivalence in the practice of advanced genetic healthcare: towards an ethical choreography

Article Link

Year:

2023

Between desire and fear: a qualitative interview study exploring the perspectives of carriers of a genetic condition on human genome editing

Article Link

Year:

2023

“What if” should precede “whether” and “how” in the social conversation around human germline gene editing

Article Link

Year:

2023

Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials

Article Link

Year:

2023

Neonatal mortality and morbidity in Down syndrome in the time of prenatal aneuploidy testing: a retrospective cohort study

Article Link

Year:

2022

Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders

Article Link

Year:

2022

Costs, burdens and the prevention of genetic disorders: what role for professional influence?

Article Link

Year:

2021

Moving somatic gene editing to the clinic: routes to market access and reimbursement in Europe

Article Link

Year:

2021

Collaborators7

Peter van de Ven

Associate Professor

University Medical Center Utrecht, Utrecht University

NETHERLANDS

Patrick Souverein

Utrecht University

NETHERLANDS

Tessel Rigter

University of Amsterdam

NETHERLANDS

Bert Jan Lietaert Peerbolte

University of Amsterdam

NETHERLANDS

Marc Van Mil

University Medical Center Groningen

NETHERLANDS

Marike Polak

Erasmus University Rotterdam

NETHERLANDS

Jesse Swen

Full professor of clinical pharmacy, in particular translational pharmacogenetics

Leiden University Medical Center

NETHERLANDS

How do I reach out?

Meet Kite AI